ArticleDiabetes, obesity & metabolism2026
Influenza Vaccination Among Individuals With Type 1 Diabetes in Denmark: Coverage, Persistence, and Determinants, 2015-2022.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influenza Vaccination Among Individuals With Type 1 Diabetes in Denmark: Coverage, Persistence, and Determinants, 2015-2022.Diabetes, obesity & metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
aimsTo investigate influenza vaccination coverage (IVC) and persistence with annual influenza vaccination among individuals with type 1 diabetes in Denmark and to identify clinical, demographic, and socioeconomic factors associated with vaccination status. MATERIALS AND
methodsWe conducted a nationwide, register-based cohort study of individuals aged 1-64 years with type 1 diabetes across the influenza seasons 2015-2022 in Denmark. Annual influenza vaccination status was assessed, and the cohort was stratified into age groups (1-18 and 19-64 years) according to age-specific vaccine recommendations. We investigated associations between non-vaccination/non-persistence and demographic, clinical, and socioeconomic factors using Poisson regression to compute adjusted relative risk (aRR). Persistence was defined as receipt of influenza vaccination in more than 80% of eligible seasons during follow-up.
resultsWe identified 25 473 individuals with type 1 diabetes corresponding to 168 212 influenza seasons. In 2015/16, IVC was 5.6% in children and 18.3% in adults. IVC remained stable until a marked increase in 2021/22 (15.7% and 41.8%, respectively). In children, longer diabetes duration, HbA1c ≥ 53 mmol/mol, and residence in The North Denmark Region were associated with non-vaccination. In adults, male sex, younger age, shorter educational attainment, and HbA1c ≥ 53 mmol/mol were associated with non-vaccination. In both populations, factors associated with non-persistence were similar to those observed with non-vaccination.
conclusionsIn Denmark, IVC among individuals with type 1 diabetes remains well below WHO targets, highlighting the need for targeted vaccination strategies. Sociodemographic and clinical factors associated with non-vaccination identify population groups where preventive efforts should be prioritised.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.